Dr. Meghan E. Sise, MD

Dr. Sise practices at Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham.

Dr. Sise's NPI, 1003043571, was assigned on June 11, 2009. Dr. Sise graduated from Columbia University College of Physicians and Surgeons in 2009. Dr. Sise holds Massachusetts license 249274.

Dr. Sise's primary practice is Massachusetts General Hospital, at 55 Fruit Street, Boston, MA 02114 in Suffolk County. The practice phone is (617) 726-2000.

Dr. Sise's primary practice is Massachusetts General Hospital in Boston, Massachusetts, part of Mass General Brigham. Dr. Sise is also affiliated with Brigham and Women's Hospital. The medical group on file is Massachusetts General Physicians Organization (MGPO). Dmand AI also links Dr. Sise to 3 more hospitals, 3 group practices and clinics, 2 medical groups and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sise practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Sise's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Sise is board certified in internal medicine by the American Board of Internal Medicine. Dr. Sise is licensed in Massachusetts.

CMS data shows 434 Medicare services from Dr. Sise across 8 procedure codes in 2024, for 213 Medicare patients. Medicare paid $43,127 for them.

CMS counts 213 Medicare patients who saw Dr. Sise in 2024. The largest group is 65 to 74, with 87 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 33% are also on Medicaid. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sise's median patient age at 71, with 52% women.

In 2024, Dr. Sise wrote 351 Medicare Part D claims for 86 patients. 89% of them were for generic drugs. CMS names the drug for 237 of them, across 9 drugs with 11 or more claims each, at $22,564 in total drug cost. In 2023, CMS named 261 claims across 10 drugs.

Dr. Sise accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sise as offering telehealth.

Dmand AI links 140 papers to Dr. Sise, published from 2011 to 2025. 2020 was the busiest year, with 22. The most frequent topics are Acute Kidney Injury, Antiviral Agents and Immune Checkpoint Inhibitors. Dr. Sise has published most often in J Immunother Cancer. Dr. Sise's most frequent co-authors are Qiyu Wang, MD, Kenar Dinesh Jhaveri, MD and Raymond T. Chung, MD.

Dmand AI links Dr. Sise to 10 clinical trials, 4 of them phase 2 studies. 9 are still active or recruiting. Conditions studied include Adenocarcinoma of Lung, Biliary Atresia and Low Back Pain.

CMS Open Payments shows 68 general payments to Dr. Sise from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 53% of the total. Bristol-Myers Squibb Company paid the most, $50,000. It also lists 4 research payments totaling $645 in 2017.

Dr. Sise graduated from Columbia University College of Physicians and Surgeons in 2009.